Literature DB >> 14575628

Management of Chronic Aortic Regurgitation.

Donald D. Glower1.   

Abstract

Aortic regurgitation may be the most treacherous of the valvular lesions due to subtlety of symptoms and physical findings and due to difficulty in timing surgical intervention to prevent permanent cardiac dysfunction. Cardiac imaging (eg, echocardiography or magnetic resonance) is critical to quantify the degree of regurgitation and to detect significant left ventricular dysfunction or dilation. Stress testing can be useful in timing surgical intervention in borderline cases. Medical therapy consists of afterload reduction, diuresis, and inotrope administration. Surgical therapy today consists of aortic valve repair in a minority of cases or aortic valve replacement in the remainder. Percutaneous means to replace the aortic valve are in development. Cardiac decompensation may require cardiac transplantation.

Entities:  

Year:  2003        PMID: 14575628     DOI: 10.1007/s11936-003-0040-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  22 in total

1.  Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.

Authors:  Philippe Menasché; Albert A Hagège; Jean-Thomas Vilquin; Michel Desnos; Eric Abergel; Bruno Pouzet; Alain Bel; Sorin Sarateanu; Marcio Scorsin; Ketty Schwartz; Patrick Bruneval; Marc Benbunan; Jean-Pierre Marolleau; Denis Duboc
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

2.  Percutaneous aortic valve replacement: an experimental study. I. Studies on implantation.

Authors:  Georg Lutter; Daniela Kuklinski; Georg Berg; Patrick Von Samson; Juergen Martin; Michael Handke; Peter Uhrmeister; Friedhelm Beyersdorf
Journal:  J Thorac Cardiovasc Surg       Date:  2002-04       Impact factor: 5.209

3.  Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function.

Authors:  Hari P Chaliki; Dania Mohty; Jean-Francois Avierinos; Christopher G Scott; Hartzell V Schaff; A Jamil Tajik; Maurice Enriquez-Sarano
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

4.  Intermediate-term durability of bicuspid aortic valve repair for prolapsing leaflet.

Authors:  F P Casselman; A M Gillinov; R Akhrass; V Kasirajan; E H Blackstone; D M Cosgrove
Journal:  Eur J Cardiothorac Surg       Date:  1999-03       Impact factor: 4.191

Review 5.  Vasodilator therapy for chronic aortic and mitral regurgitation.

Authors:  P A Grayburn
Journal:  Am J Med Sci       Date:  2000-09       Impact factor: 2.378

6.  Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation.

Authors:  M Banaszewski; W Rydlewska-Sadowska; S Rubkiewicz
Journal:  J Heart Valve Dis       Date:  1998-09

Review 7.  ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

8.  Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial.

Authors:  B Greenberg; B Massie; J D Bristow; M Cheitlin; D Siemienczuk; N Topic; R A Wilson; J Szlachcic; D Thomas
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690

9.  Acute ascending aortic dissection.

Authors:  W G Wolfe
Journal:  Ann Surg       Date:  1980-11       Impact factor: 12.969

Review 10.  Chronic aortic regurgitation. Role of medical therapy and optimal timing for surgery.

Authors:  R O Bonow
Journal:  Cardiol Clin       Date:  1998-08       Impact factor: 2.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.